Radical prostatectomy is the most effective form of therapy for prostate cancer when the tumour is organor specimen-con®ned at the time of surgery. Many preoperative clinical variables have been proposed to predict pathological stage and to identify patients at risk for failure. Of the histological variables, the Gleason histological score has been studied most extensively and has been shown to be reliable prognostic value. Some authors, however, have pointed out that the subjective histological grading required for the Gleason score is characterised by low reproducibility. Furthermore, the Gleason score depends solely on the architecture of prostate cancer tissue and does not consider features related to the size, shape or arrangement of the nucleus or proliferation.
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Estimates of volume-weighted mean nuclear volume (MNV) are the only means by which unbiased estimates of three-dimensional parameters can be obtained from a single two-dimensional section, with stereological methods. We have reported that MNV calculated by stereology is a powerful predictor of the prognosis of prostate cancer Ð as is cancer cell architecture, on which Gleason score depends. The present study was conducted to elucidate the role of MNV in predicting tumour biology for patients treated with radical prostatectomy.
Methods
A retrospective prognostic study of 71 patients with T1/ T2 disease, treated with radical prostatectomy alone, was performed. MNV was estimated using biopsy specimens based on a stereological method, and was compared with other preoperative clinical variables. For patients with prostate speci®c antigen (PSA) failure, we determined the correlation of MNV with PSA doubling time (PSA DT) which was calculated using PSA values obtained with an ultrasensitive assay.
Results
Mean MNVs for pathologically organ-con®ned and non-organ-con®ned tumours were 198.93 mm 3 and 236.33 mm 3 , respectively; this difference was signi®cant (P 0.0364). Univariate analysis showed that PSA, MNV and Gleason score were signi®cant predictors of prognosis (P 0.0126, 0.0148 and 0.0375, respectively). Multivariate analysis revealed that MNV and preoperative PSA were powerful independent predictors of prognosis (P 0.0160 and P 0.0147, respectively), but Gleason score was not correlated with prognosis (P 0.4120). For patients with PSA failure, PSA DT was signi®cantly correlated with MNV (r À0.597, P 0.0099). When these patients were classi®ed using median PSA DT at 179 days into two groups, MNV was signi®cantly larger in the PSA rapid-riser group than in the slow-riser group (P 0.0008), but no differences were observed between these groups in PSA, Gleason score or cancer volume.
Conclusion
The ®ndings of this study suggest that MNV is a powerful predictor of PSA failure for patients with clinically organcon®ned disease treated with radical prostatectomy. More importantly, they suggest that MNV can be a useful new parameter for prediction of tumor biology for patients with PSA failure after radical prostatectomy.
